Neil Sankar, Jeffrey A. Bacha, Sophia Frentzas, Malaka Ameratunga, Amy Body, Daphne Day, Richard Kelly, Jeremy Neeman, Sarath Kanekal, Ian Nisbet, Kathy Skoff, Dennis Brown. "An ongoing phase 1–2a study of EO1001, an oral brain-penetrant pan-ErbB inhibitor, in patients with advanced ErbB-driven solid tumors including CNS disease.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps8681